Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Kriya Therapeutics

Request full access

Innovative gene therapies targeting prevalent chronic diseases

Morrisville, United StatesFounded 2019Biotech & Life Sciences

Kriya Therapeutics in the Morrisville ecosystem

Live from Dealroom

The Kriya Therapeutics office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

18 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A8 investors entered at this stage

  • Asia Alpha
  • Foresite Capital
  • Amplo
  • Dexcel Pharma
  • Paul Manning
  • Narya Capital
  • QVT Financial LP
  • Bluebird Ventures

Series B and later10 investors entered at this stage

  • Woodline Partners
  • Lightswitch Capital
  • Premji Invest
  • CAM Capital
  • Patient Square Capital
  • JDRF T1D Fund
  • Thiel Capital
  • Transhuman Capital
  • Alumni Ventures
  • Hongkou
Employees mapped 201 incl. 2 AI specialists
Founders Hidden — book a demo/100 quality score
Key operators 5 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Patents

Estimated portfolio value
$415k

11 active patent families included in this estimate.

A patent family groups patent filings for the same invention. Source: Dealroom · PatSnap.

Explore the patent portfolioPatent records, technology areas and peer comparisonsBook a demo

Investments and acquisitions

Disclosed deals where Kriya Therapeutics was the backer or acquirer, 2022–2023. Toggle between venture rounds, M&A, or both. The map below is grouped by the target company's sector — the colored pill on each chip is the round type.

Portfolio analysis

3 deals across Kriya Therapeutics's capital deployment.

Where the deals concentrate by sector, stage, and decade.

By sectorCount
    By stageCount
      By periodCount

        Where Kriya Therapeutics deploys vs peers

        Each axis is a Dealroom topic tag — picked from the cluster's most-tagged themes. Values are normalized per axis: the peer with the highest tag-coverage on that axis sits at the edge, others scale relative to them. Toggle between M&A, venture, or both.

        Compare against

        Kriya Therapeutics's portfolio, mapped.

        Stage
        Period
        3 of 3 deals

        See Kriya Therapeutics on the full Dealroom platform

        Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.